97189 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
ANTIBODY CAPABLE OF SPECIFICALLY BINDING TO HUMAN ENDOTHELIN RECEPTOR, AND USE THEREOF IN TREATMENT OF DIABETIC NEPHROPATHY AND CHRONIC NEPHROPATHY
#2Amino Acid Sequences Directed Against the Melanocortin 4 Receptor and Polypeptides Comprising the Same for the Treatment of MC4R-Related Diseases and Disorders
#3ENGINEERED IgG MOLECULES AND METHODS OF USE THEREOF
#4APELIN RECEPTOR BINDING POLYPEPTIDES AND METHODS
#5METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATASE ACTIVITY IN THE CNS
#6FORMULATIONS FOR ANTI-INSULIN RECEPTOR ANTIBODY AND USES THEREOF
#7MODULATORS
#8USE OF NATURAL PROTEIN TSH AS AN ANTIGEN-BINDING SITE IN CONSTRUCTION OF CAR-T CELLS TARGETING TSHR
#9ANTI-GLP-1R ANTIBODIES AND USES THEREOF
#10METHOD OF CONJUGATION OF CYS-MABS
#11BIFUNCTIONAL DEGRADERS FOR THE TREATMENT OF GRAVES DISEASE
#12LEPTIN THERAPY FOR GLUCOSE METABOLISM DISORDERS
#13METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS
#14ANTI-TSHR ANTIBODIES AND USES THEREOF
#15SSTR-BINDING ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS
#16METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS
#17Methods and Compositions Relating to GLP1R Variants
#18IMMUNOGLOBULIN PROTEINS THAT BIND TO NPR1 AGONISTS
#19TARGETED MODIFIED TNF FAMILY MEMBERS
#20TREATING CANCER
#21METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY
#22HUMANIZED NON-OPIOID COMPOSITION AND THERAPIES FOR PAIN MANAGEMENT
#23Polypeptide Fragment Thyroid Hormone Receptor BETA1 (THRB)-CVD20, and Polyclonal Antibody Prepared Using the Same and Use Thereof
#24HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
#25LEPTIN RECEPTOR AGONISTIC ANTIBODY AS MONO OR COMBO THERAPIES TO TREAT OBESITY
#26ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
#27GLUCAGON RECEPTOR AGONISTS AND CONJUGATES TO GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE ANTAGONISTS
#28Antibodies That Bind GLP1R
#29Bispecific Binding Molecules That Target FSHR and CD3
#30COMPOSITIONS AND METHODS FOR INDUCING HUMORAL AND CELLULAR IMMUNITIES AGAINST TUMORS AND CANCER
#31USE OF FSH-RECEPTOR LIGANDS FOR DIAGNOSIS AND THERAPY OF ATHEROSCLEROSIS
#32METHODS OF TREATING DISORDERS USING ANTI-NATRIURETIC PEPTIDE RECEPTOR 1 (NPR1) ANTIBODIES
#33Bispecific Natural Killer Engagers That Target Siglec-7
#34METHODS AND COMPOSITIONS FOR INCREASING GALACTOSIDASE BETA-1 ACTIVITY IN THE CNS
#35GROWTH HORMONE RECEPTOR TARGETING POLYPEPTIDES
#36NOVEL ANTIBODIES AND ANTIBODY CONJUGATES FOR THE TREATMENT OF METABOLIC DISORDERS
#37NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF
#38Antibodies that Bind CD3 Epsilon
#39Methods and Compositions Relating to Adenosine Receptors
#40PRLR ANTIGEN-BINDING PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF
#41HUMAN CGRP RECEPTOR BINDING PROTEINS
#42CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS
#43MODULATORS OF INTEROCEPTION
#44BOREALIN TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER
#45METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GLP-1 RECEPTOR AGONISTS CONJUGATED TO ANTAGONISTS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR)
#46METHOD FOR PRODUCING AN ANTIBODY PEPTIDE CONJUGATE
#47METHODS OF TREATING UREA CYCLE DISORDERS BY INTERFERING WITH GLUCAGON RECEPTOR SIGNALING
#48ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR
#49HUMANIZED ANTI-PACAP ANTIBODIES AND USES THEREOF
#50GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS AND USES THEREOF
#51MECHANICALLY INTERLOCKING COMPLEXES
#52ANTI-TSHR MULTI-SPECIFIC ANTIBODIES AND USES THEREOF
#53METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACTIVITY IN THE CNS
#54Novel Immune Cell Engagers For Immunotherapy
#55INCENP TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER
#56ANTI-AMHRII ANTIBODIES
#57BISPECIFIC T-CELL ENGAGERS TARGETING FSHR AND METHODS OF USE IN CANCER THERAPUTICS
#58HUMANIZED ANTIBODIES THAT BIND LGR5
#59TARGETED DELIVERY OF THERAPEUTIC ENZYMES
#60LOW-VISCOSITY ANTIGEN BINDING PROTEINS AND METHODS OF MAKING THEM
#61METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATE ACTIVITY IN THE CNS
#62ANTI-NPR1 ANTIBODIES AND USES THEREOF
#63ANTI-GIPR ANTIBODY AND METHODS OF USE THEREOF
#64THERAPEUTICS AND METHODS FOR TREATING OR AMELIORATING METABOLIC DISORDERS
#65METHODS AND COMPOSITIONS FOR INCREASING THE ACTIVITY IN THE CNS OF HEXOSAMINIDASE A, ACID SPHINGOMYELINASE, AND PALMITOYL-PROTEIN THIOESTERASE 1
#66Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A
#67ANTIBODY-CONJUGATED NANOPARTICLES AND MEDICAL USES THEREOF
#68POLYPEPTIDES WITH ALTERED BINDING TO NEONATAL FC RECEPTOR (FCRN) AND METHODS OF USE
#69Applications of GHR-106 Monoclonal Antibody as a GnRH Antagonist
#70PARATHYROID HORMONE RECEPTOR 1(PTH1R) ANTIBODIES AND USES THEREOF
#71BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND LEPTIN RECEPTOR AND/OR GP130, AND METHODS OF USE THEREOF
#72PAC1 ANTIBODIES AND USES THEREOF
#73ANTI-GLP1R ANTAGONIST ANTIBODIES AND METHODS OF USE THEREOF
#74ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
#75APLNR Modulators and Uses Thereof
#76GLUCAGON RECEPTOR BINDING PROTEINS AND METHODS OF USE THEREOF
#77ANTI-NPR1 ANTIBODIES AND USES THEREOF
#78PREPARATION AND USE OF ANTI-FSHR ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF
#79Glucagon-like peptide 1 receptor agonists and uses thereof
#80METHODS OF TREATING SEVERE INSULIN RESISTANCE BY INTERFERING WITH GLUCAGON RECEPTOR SIGNALING
#81NATRIURETIC PEPTIDE RECEPTOR 1 ANTIBODIES AND METHODS OF USE
#82AMH-COMPETITIVE ANTAGONIST ANTIBODY
#83ETAR ANTIBODY, AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
#84NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#85METHODS FOR TREATING SHORT BOWEL SYNDROME AND/OR HIGH OUTPUT OSTOMY
#86CD28 COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR THERAPY
#87SERS-NANOTAG AND DIAGNOSTIC KIT FOR DETECTING BREAST CANCER BIOMARKERS
#88CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#89ANTI-MULLERIAN HORMONE RECEPTOR BINDING PEPTIDES
#90METHODS AND COMPOSITIONS FOR IN VITRO AFFINITY MATURATION OF MONOCLONAL ANTIBODIES
#91METHODS AND COMPOSITIONS FOR INCREASING ALPHA-L-IDURONIDASE ACTIVITY IN THE CNS
#92TARGETED MODIFIED IL-1 FAMILY MEMBERS
#93ANTIGEN-BINDING PROTEINS THAT ANTAGONIZE LEPTIN RECEPTOR
#94SSTR-2 Binding Chimeric Antigen Receptors
#95AMHRII-BINDING COMPOUNDS FOR PREVENTING OR TREATING LUNG CANCERS
#96HUMAN ENDOTHELIN RECEPTOR A (ETAR) ANTAGONIST ANTIBODIES
#97VARIANT NUCLEIC ACID LIBRARIES FOR GLP1 RECEPTOR
#98Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels
#99ANTI-PACAP ANTIBODIES AND USES THEREOF
#100Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
#101ANTI-MULLERIAN HORMONE RECEPTOR 2 ANTIBODIES AND METHODS OF USE
#102COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST AND A GLP-1 RECEPTOR AGONIST
#103INHIBITORS OF ADRENOMEDULLIN FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA BY ERADICATING LEUKEMIC STEM CELLS
#104METHODS FOR TREATING OR PREVENTING MIGRAINE HEADACHE
#105USE OF COMPOSITION FOR ENHANCING ANTICANCER EFFECT, COMPRISING ERRy INHIBITOR AS ACTIVE INGREDIENT
#106METHOD OF TREATING CANCER AND METHOD OF SENSITIZING CANCER CELLS TO THE ACTION OF CHEMOTHERAPEUTIC AGENTS VIA GROWTH HORMONE RECEPTOR ANTAGONISTS OR KNOCK DOWN
#107GIPR ANTIBODY AND FUSION PROTEIN BETWEEN SAME AND GLP-1, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
#108METHOD OF TREATING OR AMELIORATING CUSHING'S SYNDROME USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR)
#109Long-lasting GLP1 analogue drug for type-2 diabetes
#110FUSION PROTEINS FOR DELIVERY OF GDNF TO THE CNS
#111ANTI-CGRP RECEPTOR/ANTI-PAC1 RECEPTOR BISPECIFIC ANTIGEN BINDING PROTEINS
#112NATRIURETIC PEPTIDE RECEPTOR 1 ANTIBODIES AND METHODS OF USE
#113NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#114ERENUMAB COMPOSITIONS AND USES THEREOF
#115METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS
#116Targeted modified TNF family members
#117NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#118MONOCLONAL ANTIBODIES TO ANGIOTENSIN-(1-12), COMPOSITIONS INCLUDING THE SAME, AND METHODS OF USE THEREOF
#119GPCR BINDING PROTEINS AND SYNTHESIS THEREOF
#120METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY
#121Peptides and combination of peptides for use in immunotherapy against various cancers
#122Peptides and combination of peptides for use in immunotherapy against various cancers
#123ANTIBODY TO LEPTIN RECEPTOR
#124NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#125LONG-LASTING GLP1 ANALOGUE DRUG FOR TYPE-2 DIABETES
#126Peptides and combination of peptides for use in immunotherapy against various cancers
#127Peptides and combination of peptides for use in immunotherapy against various cancers
#128Peptides and combination of peptides for use in immunotherapy against various cancers
#129FUSION PROTEIN OF ETA ANTIBODY AND TGF-BETA TRAP AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
#130Methods and compositions relating to adenosine receptors
#131Peptides and combination of peptides for use in immunotherapy against various cancers
#132Peptides and combination of peptides for use in immunotherapy against various cancers
#133Estrogen receptor mutations and uses thereof
#134Peptides and combination of peptides for use in immunotherapy against various cancers
#135GHR-106 CHIMERIC ANTIGEN RECEPTOR CONSTRUCT AND METHODS OF MAKING AND USING SAME
#136ANTIBODY WITH ENHANCED BINDING AFFINITY FOR ENDOTHELIN RECEPTOR TYPE A
#137VECTOR-BASED THERAPY FOR THYROID DISEASE
#138NOVEL MODULATORS
#139APJ MODULATORS AND USES THEREOF
#140Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A
#141MÜLLERIAN INHIBITING SUBSTANCE TYPE 2 RECEPTOR (MISIIR)-SPECIFIC CAR T CELLS FOR THE TREATMENT OF OVARIAN CANCER AND OTHER GYNECOLOGIC MALIGNANCIES
#142Anti-NPR1 antibodies and uses thereof
#143Synthetic immune receptors and methods of use thereof
#144IMMUNOGLOBULIN PROTEINS THAT BIND TO NPR1 AGONISTS
#145Monoclonal Antibodies to ELTD1 and Uses Thereof
#146Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
#147Heterodimeric antibodies that bind somatostatin receptor 2
#148BISPECIFIC PROTEIN
#149AMHRII-BINDING COMPOUNDS FOR PREVENTING OR TREATING CANCERS
#150Antibodies against hEPCR
#151METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACTIVITY IN THE CNS
#152Methods Of Treating Type 2 Diabetes Mellitus Using Glucagon Receptor Antagonistic Antibodies
#153Antigen-binding proteins that activate the leptin receptor
#154Use of LEPR Agonists for Pain
#155Antibody against the endothelin receptor subtype A, and uses thereof
#156Anti-mullerian hormone receptor binding peptides
#157METHODS AND COMPOSITIONS RELATING TO GLP1R VARIANTS
#158ACTRIIB PROTEINS AND VARIANTS AND USES THEREFORE RELATING TO UTROPHIN INDUCTION FOR MUSCULAR DYSTROPHY THERAPY
#159Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)
#160METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA BY ERADICATING LEUKEMIC STEM CELLS
#161Ultra-long acting insulin-Fc fusion proteins and methods of use
#162Ultra-long acting insulin-Fc fusion proteins and methods of use
#163Multispecific antigen-binding molecules and uses thereof
#164PURIFICATION OF IDURONATE-2-SULFATASE IMMUNOGLOBULIN FUSION PROTEIN
#165CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS
#166METHODS AND COMPOSITIONS FOR INCREASING GALACTOSIDASE BETA-1 ACTIVITY IN THE CNS
#167Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody
#168Low-viscosity antigen binding proteins and methods of making them
#169Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)
#170Peptides and combination of peptides for use in immunotherapy against various cancers
#171METHOD OF CONJUGATION OF CYS-MABS
#172Peptides and combination of peptides for use in immunotherapy against various cancers
#173Therapeutic antibody fragments, methods of making, and methods of use
#174Neuroendocrine cancer targeted therapy
#175Anti-Follicule Stimulating Hormone Receptor Antibodies
#176Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor
#177Fusion protein comprising IDS and use thereof
#178Peptides and combination of peptides for use in immunotherapy against various cancers
#179Peptides and combination of peptides for use in immunotherapy against various cancers
#180Combination therapy with a glucagon receptor (GCGR) antibody and an anti-CD3 antibody
#181Peptides and combination of peptides for use in immunotherapy against various cancers
#182Glucagon-like peptide 1 receptor agonists and uses thereof
#183Methods of Treating Conditions with Antibodies that Bind Colony Stimulating Factor 1 Receptor (CSF1R)
#184NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#185METHOD OF MODULATING THE CONCENTRATION OF PROTEINS IN CEREBROSPINAL FLUID
#186Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof
#187DEVICES, METHODS, COMPOSITIONS AND SYSTEMS FOR THE TREATMENT OF AGING AND AGE-RELATED DISORDERS
#188Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS
#189TARGETING OF HUMAN INTERFERON ANTAGONISTS
#190Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
#191MONOCLONAL ANTIBODY FUSIONS
#192VARIANT NUCLEIC ACID LIBRARIES FOR ADENOSINE RECEPTORS
#193Human CGRP receptor binding proteins
#194Human CGRP receptor binding proteins
#195Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies
#196Chimeric antigen receptor comprising third signal receptor and use thereof
#197APJ antibody, fusion protein thereof with Elabela, and pharmaceutical compositions and use thereofus01
#198METHODS FOR MAKING STABLE PROTEIN COMPOSITIONS
#199TARGETED HUMAN-INTERFERON FUSION PROTEINS
#200COMPOSITIONS AND METHODS FOR TREATING MELANOMA WITH A CHIMERIC ANTIGEN RECEPTOR
#201Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)
#202Antibodies against the human fshr extracellular domain
#203Methods of treating urea cycle disorders by interfering with glucagon receptor signaling
#204PROLACTIN RECEPTOR ANTIBODY FOR MALE AND FEMALE PATTERN HAIR LOSS
#205GCGR antibody and GLP-1 fusion protein thereof, pharmaceutical composition thereof and application thereof
#206Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof
#207Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants
#208Antibodies that bind CD3 epsilon
#209METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS
#210Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof
#211Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof
#212METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACTIVITY IN THE CNS
#213Ultra-long acting insulin-Fc fusion proteins and methods of use
#214Ultra-long acting insulin-Fc fusion proteins and methods of use
#215COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF
#216Natriuretic peptide receptor 1 antibodies and methods of use
#217Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors
#218CGRP ANTAGONISTS FOR THE TREATMENT OF MEDICATION OVERUSE HEADACHE, POST-TRAUMATIC HEADACHE, POST-CONCUSSION SYNDROME AND VERTIGO
#219Method of inhibiting the gonadotropin-releasing hormone (GnRH) receptor by administering a GHR-106 monoclonal antibody
#220Methods for treating heart failure using glucagon receptor antagonistic antibodies
#221Methods For Treating Obesity And Nonalcoholic Fatty Liver Disease Or Nonalcoholic Steatohepatitis Using Glucagon Receptor Antagonistic Antibodies
#222Variant nucleic acid libraries for GLP1 receptor
#223Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof
#224METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS
#225Targeted modified TNF family members
#226TARGETED MODIFIED IL-1 FAMILY MEMBERS
#227FUSION PROTEINS FOR DELIVERY OF GDNF TO THE CNS
#228Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels
#229Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies
#230Ultra-long acting insulin-Fc fusion proteins and methods of use
#231Integral membrane protein display on poxvirus extracellular enveloped virions
#232Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
#233Humanized anti-PACAP antibodies
#234Humanized anti-PACAP antibodies
#235Human PAC1 antibodies
#236Methods and compositions for generation of binding agents against cell surface antigens
#237Humanized anti-PACAP antibodies
#238DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-LGR7 ANTIBODY
#239Ultra-long acting insulin-Fc fusion proteins and methods of use
#240Ultra-long acting insulin-Fc fusion proteins and methods of use
#241Ultra-long acting insulin-FC fusion proteins and methods of use
#242CANCER-ASSOCIATED IMMUNOSUPPRESSION INHIBITOR
#243Antigen-binding proteins that antagonize leptin receptor
#244Anti-NPR1 antibodies and uses thereof
#245COMBINATION OF ANT-CD303 AND ANTI-AMHRII ANTIBODIES
#246Peptides and combination of peptides for use in immunotherapy against various cancers
#247Methods for detecting 1,25-dihydroxyvitamin D and related antibodies
#248Bi-specific antibodies and uses thereof
#249Method of treating type I diabetes by administering a combination of a glucagon receptor antagonist and an anti-CD3 antibody
#250ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR
#251COMBINATION THERAPIES
#252CHIMERIC ANTIGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USE THEREOF
#253Human follicle-stimulating hormone receptor (FSHR) extracellular domain antibodies and methods of use thereof
#254Peptides and combination of peptides for use in immunotherapy against various cancers
#255METHODS OF TREATMENT FOR CANCER, STEROL HOMEOSTASIS, AND NEUROLOGICAL DISEASES
#256Methods and compositions for increasing alpha-L-iduronidase activity in the CNS
#257HUMANIZED ANTIBODIES THAT BIND LGR5
#258Antibody against human prostaglandin E2 receptor EP4
#259CD28 compositions and methods for chimeric antigen receptor therapy
#260METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND ENHANCING TUMOR VACCINES
#261Methods of screening compounds useful for treatment of a liver disease
#262AMHRII-BINDING COMPOUNDS FOR PREVENTING OR TREATING CANCERS
#263Targeted modified TNF family members
#264GHR-106 CHIMERIC ANTIGEN RECEPTOR CONSTRUCT AND METHODS OF MAKING AND USING SAME
#265Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock down
#266Methods of treatment using a leptin receptor agonist antibody
#267MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF
#268Erenumab compositions and uses thereof
#269Integral membrane protein display on poxvirus extracellular enveloped virions
#270Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
#271BLOCKERS OF THE GROWTH HORMONE RECEPTOR IN DISEASE PREVENTION AND TREATMENT
#272ANTIBODY-CONJUGATED NANOPARTICLES AND MEDICAL USES THEREOF
#273Peptides and combination of peptides for use in immunotherapy against various cancers
#274Peptides and combination of peptides for use in immunotherapy against various cancers
#275Methods for treating or preventing migraine headache
#276Heterodimeric antibodies that bind somatostatin receptor 2
#277Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells
#278NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF
#279Low-viscosity antigen binding proteins and methods of making them
#280Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators
#281Anti-PACAP antibodies and uses thereof
#282CELL CULTURE IMPROVEMENTS
#283Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
#284PAC1 antibodies and uses thereof
#285TARGETED MODIFIED IL-1 FAMILY MEMBERS
#286Antibody directed against the endothelin receptor beta sub-type
#287Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof
#288Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS
#289Fusion protein comprising apelin and an anti-APLNR antibody
#290Combination of glucagon receptor antagonists and PI3K pathway inhibitors for the treatment of cancer
#291PROLACTIN RECEPTOR BINDING PROTEINS AND USES THEREOF
#292Chimeric antigen receptors and uses thereof
#293Generating targeted sequence diversity in fusion proteins
#294Nucleic acid molecules encoding antibodies to the human glucagon receptor
#295Modular, controlled single chain variable fragment antibody switch
#296MIGRAINE, HEADACHE, CHRONIC PAIN TREATMENT, AND PROPHYLAXIS OPTIONS
#297GPCR binding proteins and synthesis thereof
#298ETAR ANTIBODY, AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF
#299Integral membrane protein display on poxvirus extracellular enveloped virions
#300Anti-DEspR inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery